Who is sponsoring NCT03211338?

NCT03211338 is sponsored by Hillel Yaffe Medical Center.

What drugs are being tested in NCT03211338?

Interventions in NCT03211338: Culture with progesterone, Culture without progesterone, Culture with growth factors.

What condition does NCT03211338 study?

NCT03211338 studies Obstetric Labor, Premature.

Is NCT03211338 still recruiting?

NCT03211338 is currently completed. Last updated 23 June 2022.

Last reviewed 2022-06-23 · How we verify

NCT03211338

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone

Completed NA Last updated 23 June 2022

What this trial tests

NA trial testing Culture with progesterone in Obstetric Labor, Premature in 115 participants. Completed in 6 June 2022.

Timeline

15 July 2017

Primary endpoint
6 June 2022

6 June 2022

Quick facts

Lead sponsor	Hillel Yaffe Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	115
Start date	15 July 2017
Primary completion	6 June 2022
Estimated completion	6 June 2022
Sites	1 location across Israel

Drugs / interventions tested

Culture with progesterone — full drug profile →
Culture without progesterone — full drug profile →
Culture with growth factors — full drug profile →

Conditions studied

Obstetric Labor, Premature — all drugs for Obstetric Labor, Premature →

Sponsor

Hillel Yaffe Medical Center

Who can join

Adults 18 to 40, female only, with Obstetric Labor, Premature. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the In Vitro and In Vivo effect of progesterone on immature myeloid cells (IMC), inflammation characteristics and maturation into dendritic cells (DC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstetric Labor, Premature

Currently open trials in the same condition.

NCT05114096 — Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) · Phase 4 · recruiting
NCT05685745 — Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset · recruiting

Other Hillel Yaffe Medical Center trials

Trials by the same sponsor.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07134985 — Pediatric Patients Who Leave the Emergency Department Without Treatment · recruiting
NCT06927193 — Regional Analgesia at the Pediatric Emergency Department · recruiting
NCT07233525 — Home-Based Language and Cognitive Intervention for Arab Toddlers in Israel · NA · not yet recruiting
NCT07320339 — The Aim of the Study is to Examine the Variation in Blood Pressure Between an Optimal Measurement (According to Establis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03211338 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hillel Yaffe Medical Center
Last refreshed: 23 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03211338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing